Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease

Journal of Endocrinological Investigation

Volumn 35, Issue 1, 2012, Pages 8-13

  Conzo, Giovanni ^a   Perna, A F ^a   Sinisi, A A ^a   Palazzo, A ^a   Stanzione, F ^a   Della Pietra, C ^a   Livrea, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Autotransplantation; Chronic kidney disease; Parathyroidectomy; Secondary hyperparathyroidism

Indexed keywords

PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPOCALCEMIA; HYPOPARATHYROIDISM; MALE; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; RECURRENCE RISK; RECURRENT DISEASE; SECONDARY HYPERPARATHYROIDISM; TOTAL PARATHYROIDECTOMY WITHOUT AUTOTRANSPLANTATION; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84861991521     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7621     Document Type: Article

References (22)

1. Schlosser K, Veit JA, Witte S, et al. Comparison of total parathyroidectomy without autotransplantation and without thymectomy versus total parathyroidectomy with autotransplantation and with thymectomy for secondary hyperparathyroidectomy: TOPAR PILOT-Trial. Trials 2007, 8: 22.
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009, (113): S1-130.
3. Esposito MG, Cesare CM, De Santo RM, et al. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism. J Nephrol 2008, 21 (Suppl 13): S92-6.
4. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003, 42 (4 Suppl 3): S127-9.
5. Cunningham J, Danese M, Olson K, Klassen P, Chertow GM. Effects of the calcimimetic cinacalcet HCl on cardiovascular disease, fracture, and health-related quality of life in secondary hyperparathyroidism. Kidney Int 2005, 68: 1793-800. (Pubitemid 43169924)
6. Fassbinder W, Brunner FP, Brynger H, et al. Combined report on regular dialysis and transplantation in Europe, XX, 1989. Nephrol Dial Transplant 1991, 6 (Suppl 1): 5-35.
7. Tominaga Y. Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci 2006, 111: 277-92.
8. Kitagawa W, Shimizu K, Akasu H. Endocrine surgery: the tenth report diagnosis, surgical indications and operative strategy of renal hyperparathyroidism. J Nihon Med Sch 2003, 70: 278-82. (Pubitemid 36829924)
9. Decker PA, Cohen EP, Doffek BS KM, et al. Subtotal parathyroidectomy in renal failure: still needed after all these years. World J Surg 2001, 25: 708-12.
10. Malberti F, Marcelli D, Conte F, Limido A, Spotti D, Locatelli F. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 2001, 12: 1242-8. (Pubitemid 32472638)
11. Young EW, Albert JM, Satayathum S, et al. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2005, 67: 1179-87. (Pubitemid 41623345)
12. Rodriguez M, Caravaca F, Fernandez E, et al. Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient. Kidney Int 1999, 56: 306-17. (Pubitemid 29300549)
13. Narayan R, Parkins RM, Berbano EP, et al. Parathyroidectomy versus cinacalcet hydrochloride-based medical terapy in the management of hyperparathyroidism in ESRD: a cost utility analysis. Am J Kidney Dis 2007, 49: 801-13. (Pubitemid 46802934)
14. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK. Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 2001, 12: 2131-38. (Pubitemid 32880350)
15. Gasparri G, Camandona M, Mengozzi G, et al. Qu'est-ce que l'introduction du dosage peroperatoire de la PTH a changé dans les strategies chirurgicales des hyperparathyrodismes?. e-memoires de l'Académie Nationale de Chirurgie 2004, 3: 26-9.
16. Elizondo ME, Diaz Aguirregoitia FJ, Amondarain JA, Vidaur F. Intraoperative monitoring of intact PTH in surgery for renal hyperparathyroidisms as an indicator of complete parathyroid removal. World J Surg 2005; 29: 1504-9. (Pubitemid 41712691)
17. Dotzenrath C, Cupisti K, Goretzki PE, et al. Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 2003, 387: 348-54. (Pubitemid 36187845)
18. Richards ML, Wormuth J, Bingener J, Sirinek K. Parathyroidectomy in secondary hyperparathyroidism: is there an optimal operative management? Surgery 2006, 139: 174-80. (Pubitemid 43170317)
19. Lorenz K, Ukkat J, Sekulla C, Gimm O, Brauckhoff M, Dralle H. Total parathyroidectomy without autotransplantation for renal hyperparathyroidism: experience with a qPTH-controlled protocol. World Journal Surgery 2006, 30: 743-51. (Pubitemid 43724101)
20. Rayes N, Seehofer D, Schindler R, et al. Long term results of subtotal vs total parathyroidectomy without autotransplantation in kidney transplant recipients. Arch Surg 2008, 143: 756-60.
21. Jofrè R, Lopez Gomez JM, Menàrguez J, et al. Parathyroidectomy: Whom and when? Kidney Int 2003, 63 (Suppl 85) S97-100.
22. Tominaga Y, Matsuoka S, Sato T. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial 2005, 9: 44-7. (Pubitemid 40393323)